Navigation Links
Amarin Provides 2010 Year-End Review to Shareholders
Date:1/31/2011

DUBLIN and MYSTIC, Conn., Jan. 31, 2011 /PRNewswire/ -- Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today issued a special letter to its shareholders. The text of the letter, written by Joseph S. Zakrzewski, Executive Chairman and Chief Executive Officer of Amarin, follows:

Dear Shareholders:

With 2011 now underway, I am pleased to provide you with a brief review of Amarin's accomplishments in 2010 and an outline of our strategy for 2011 and beyond. In summary, 2010 was a very successful year for us, and we look forward to continued success in the year to come.

Our Recent Accomplishments Include:

  • Successful top-line results from our Phase 3 MARINE trial
  • Completed patient randomization for our Phase 3 ANCHOR trial
  • Strengthened management team and board of directors
  • Strengthened balance sheet with additional $100M cash
  • On track for a 2011 NDA submission

  • AMR101 is Positioned to Be Best-in-Class Therapy for Very High TriglyceridesIn November 2010, we announced that AMR101, Amarin's lead product candidate for the treatment of patients with very high triglycerides (>500 mg/dL), met the primary endpoint in the Phase 3 MARINE study with highly significant reductions in triglycerides from baseline compared to placebo at both the 4 gram and 2 gram doses. In addition to achieving these key endpoints, the results of this trial exceeded our expectations with no statistically significant increase in LDL-cholesterol observed at either dose, with triglyceride lowering that was greater in the predefined subset of patients on statin therapy and with encouraging results regarding prespecified markers of inflammation. Additionally, we observed in the trial a safety profile for AMR101 similar to placebo. The endpoints for this trial were establishe
    '/>"/>

    SOURCE Amarin Corporation plc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
    2. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
    3. Amarin to Present at UBS Life Sciences Conference
    4. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
    5. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
    6. Amarin Prices Public Offering of American Depositary Shares
    7. Amarin Announces Underwriters Exercise of Over-Allotment Option
    8. Amarin Announces Successful Completion of Offering of American Depositary Shares
    9. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
    10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    11. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) ... Pharmacovigilance Legislation (London, UK - November 16-17, 2015)" ... new EU modules concerning Pharmacovigilance are a major departure ... Europe . The intention of the ... requirements, examine how they overlap and fit together and ...
    (Date:9/2/2015)... -- Demers Ambulances is proud to announce it has signed ... the states of Mississippi , ... "This will enable Demers to effectively meet the ... Vice-President for Demers Ambulances. "Emergency Equipment Professionals has three service ... Alabama , giving them a strategic advantage. Local ...
    (Date:9/2/2015)... Fla. , Sept. 2, 2015  Boca ... MD, FACS, has begun performing ultra-minimally invasive left ... are on anticoagulants such as Coumadin, Xarelto or ... Surgery at the Hospital, is one of a ... which involves making two microscopic incisions in order ...
    Breaking Medicine Technology:Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3
    (Date:9/3/2015)... ... 2015 , ... The new In-Office whitening kit from Whiter ... Clinicians Report is a leading information source to the dental industry. Product reviews ... Image's In-Office whitening kits were favorably validated for use in the dental office. ...
    (Date:9/3/2015)... ... September 03, 2015 , ... Local filmmakers and now co-hosts of the ... from Path 11 Productions have had great success in launching their Path11 Podcast with ... House authors, Teal Swan who is the well known Spiritual Catalyst and Linda Howe, ...
    (Date:9/3/2015)... Lagos (PRWEB) , ... September 03, 2015 , ... ... base, robust distribution channels and efficient customer and technical support services to promote ... NAFDAC approved 90-day Bridging trial evaluating the efficacy and safety of the product. ...
    (Date:9/2/2015)... ... 03, 2015 , ... One can hardly argue against the fact that more ... and personal computers. These devices are being used as GPS, to make purchases, and ... dating apps, STD positive singles can now join the prestigious social ranks of e-dating. ...
    (Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Chris Harrison ... September 2015. “It was a simple decision, really,” says Chris. “We have a lot ... They know the brands that work best for them—so we’ve given them the convenience ...
    Breaking Medicine News(10 mins):Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2
    ... prehypertensive people in morning use, researchers report , , WEDNESDAY, ... control prehypertension, but only if it is taken at ... every morning didn,t lower the blood pressure of prehypertensive ... Hermida reported Wednesday at the American Society of Hypertension ...
    ... May 14 AstraZeneca (NYSE:,AZN) today announced that ... SEROQUEL(R) (quetiapine fumarate tablets) for the maintenance,treatment of ... to,lithium or divalproex. SEROQUEL is approved by the ... the only single agent approved by the FDA ...
    ... Amarin Corporation plc,(NASDAQ: AMRN ) today announced ... one ordinary share) ("ADSs") with several new,institutional and ... for up to $60 million funded over two ... entered into definitive agreements for,gross proceeds of up ...
    ... FRAMINGHAM, Mass., and SYDNEY, Australia, May 14 /PRNewswire-FirstCall/,-- HeartWare ... to,make an investor presentation at the Seventh Annual JMP ... on Wednesday, May 21, 2008. The,conference is being held ... live webcast of the Company,s presentation at the conference ...
    ... -- Mindray,Medical International Limited (NYSE: MR ), ... in China with a rapidly growing,international presence, today ... of strategic development and Ms. May Li, Mindray,s,investor ... Annual,China Dragon Call Conference to be held at ...
    ... Families Raise Preschoolers to Be Healthy,Eaters, SACRAMENTO, ... years old experience developmental changes that affect their ... these changes,families can help turn their preschoolers into ... ), According to Monica Montes, a ...
    Cached Medicine News:Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9Health News:Amarin Announces Private Placement for up to $60 Million 2Health News:Amarin Announces Private Placement for up to $60 Million 3Health News:Amarin Announces Private Placement for up to $60 Million 4Health News:Amarin Announces Private Placement for up to $60 Million 5Health News:HeartWare to Present at Seventh Annual JMP Securities Research Conference 2Health News:Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference 2Health News:Learning Good Eating Habits Early Leads to Lifelong Health and Wellness 2
    ... The combination of these recommendations with the ... Sorin Group has resulted in numerous improvements, ... poles and reservoir holder for hassle-free storage ... cart with just a flick of the ...
    The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
    ... Diagnostics is a clinical reference ... treatment and monitoring of hemostatic ... a collaboration of four laboratory ... defined vision to deliver customizable ...
    All-natural porcine collagen can be used in open or laparoscopic placement....
    Medicine Products: